EN PT


0227/2012 - Abortion and misoprostol: health practices and scientific controversy
Aborto e misoprostol: usos médicos, práticas de saúde e controvérsia científica

Author:

• Marilena Cordeiro Dias Villela Corrêa - CORRÊA, Marilena C. D. V. - Rio de Janeiro, Rio de Janeiro - IMS-UERJ - <mcorrea@ism.com.br>

Co-author(s):

• Miryam Mastrella - Mastrella , M. - UnB e Anis - <m.mastrella@anis.org.br>

Thematic Area:

Não Categorizado

Abstract:

This article puts into perspective the controversy between the association between use of misoprostol for abortion and teratogenicity studies of the type found in a case report, and the consecration of the use of herbal medicinal drug in the medical-obstetric and national norms and international governing the registration and circulation of pharmaceuticals. Through the monographic method, were reviewed, systematized and analyzed official documents of ANVISA, Ministry of Health and World Health Organization on the use of misoprostol, as well as 68 articles such as case reports, published in national journals, linking abortion , misoprostol and teratogenicity. The legal prohibition of abortion prevents the proper prescription and use of a drug that produces effects safe and effective as misoprostol. Thus, the great harm to the health of women is linked not to the intrinsic characteristics of the drug, but the moral arguments that represent negligence and contempt for the fundamental rights of women.

Keywords:

abortion misoprostol Moebius syndrome public health health scientific knowledge production.

Content:

Access Issue in Scielo

Other languages:







How to

Cite

CORRÊA, Marilena C. D. V., Mastrella , M.. Abortion and misoprostol: health practices and scientific controversy. Cien Saude Colet [periódico na internet] (2012/Mar). [Citado em 27/09/2024]. Está disponível em: http://cienciaesaudecoletiva.com.br/en/articles/abortion-and-misoprostol-health-practices-and-scientific-controversy/9586?id=9586



Execution



Sponsors